Share Email Print
cover

Proceedings Paper

Fluorescence quantum yield of verteporfin is independent of oxygen
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Photodynamic therapy dosimetery and treatment planning is affected by the concentration of photosensitizer in a given tissue, and these values are often estimated based on measurements of fluorescence in the region to be treated. Some studies with benzoporphyrin derivate monoacid ring a (BPD-MA) showed a significant increase in fluorescence quantum yield with deoxygenation of the solution, indicating a possible oxygen sensitive switch in intersystem crossing or reverse intersystem crossing. The experiments done in this paper show that at oxygenation levels found in vivo the variation in fluorescence quantum yield of liposomal BPD-MA (verteporfin) is negligible for changes in solution oxygenation. The results from all of the experiments show that it is not necessary to measure the oxygenation of tissues when calculating the concentration of verteporfin from fluorescence measurements, so that dosimetry calculations based upon photosensitizer levels would not be affected by the tissue oxygenation. This greatly simplifies the dosimetry process with verteporfin.

Paper Details

Date Published: 27 February 2008
PDF: 7 pages
Proc. SPIE 6845, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVII, 684517 (27 February 2008); doi: 10.1117/12.764244
Show Author Affiliations
Tim Monahan, Dartmouth College (United States)
Shudong Jiang, Dartmouth College (United States)
Brian Pogue, Dartmouth College (United States)
Wellman Ctr. for Photomedicine, Massachusetts General Hospital (United States)


Published in SPIE Proceedings Vol. 6845:
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVII
David Kessel, Editor(s)

© SPIE. Terms of Use
Back to Top